List of works - Françoise Kraeber-Bodéré

18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease

scientific article published in January 2008

18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study.

scientific article published on 30 September 2013

99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography

scientific article

A pretargeting system for tumor PET imaging and radioimmunotherapy

scientific article

A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.

scientific article published on 21 March 2007

Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

scientific article published on 5 June 2009

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer

scientific article

Assessment of a fully 3D Monte Carlo reconstruction method for preclinical PET with iodine-124

scientific article published on 05 March 2015

Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT.

scientific article published on 17 February 2013

BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principle

scientific article

Challenges in nuclear medicine: innovative theranostic tools for personalized medicine

scientific article

Clinical NECR in 18F-FDG PET scans: optimization of injected activity and variable acquisition time. Relationship with SNR.

scientific article published on 8 October 2014

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up

scientific article published on 22 July 2015

Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma

scientific article published on 20 March 2010

Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence

scientific article published on 01 March 2011

Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft

scientific article

Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.

scientific article published in February 2002

Consolidation par 90Y-epratuzumab en fractionné dans le lymphome B diffus à grandes cellules : résultats préliminaires d’une étude de phase II

Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

scientific article published on 01 July 2008

Current status and perspectives in peptide receptor radiation therapy

scientific article published on January 2009

Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials.

scientific article

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

scientific article

Does18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?

scientific article published on 01 December 2007

Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients

scientific article

Détection laparoscopique des ganglions sentinelles dans le cancer localisé de la prostate : résultats obtenus chez 70 premiers patients

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

scientific article published on 01 July 2011

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography

scientific article published on 11 February 2008

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

scientific article published on 10 February 2011

FDG-PET in Follicular Lymphoma Management ⬇️

scientific article published on July 30, 2012

Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.

scientific article published in December 2005

First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumors.

scientific article

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging

scientific article

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

scientific article published on 2 December 2013

High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer

scientific article published on 30 November 2004

High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma

scientific article published on 12 July 2010

Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".

scientific article

Immuno-PET for Clinical Theranostic Approaches ⬇️

scientific article published on 28 December 2016

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients

scientific article published on 31 May 2010

Improvement of radioimmunotherapy using pretargeting

scientific article published on 20 June 2013

Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.

scientific article published in July 2013

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma

scientific article

Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients

scientific article published on 31 March 2014

Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma

scientific article published on 16 November 2011

Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data

scientific article

Le point sur les avancées récentes de la radio-immunothérapie alpha

scientific article published on 28 June 2007

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

scientific article published on 18 February 2017

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients

scientific article

Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors.

scientific article

Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations

scientific article

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

article

Phéochromocytomes bilatéraux. Génétique et traitement

scientific article published on 01 April 2005

Preoperative localization of parathyroid lesions

scientific article published on 01 January 2008

Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)

scientific article published on 07 March 2012

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer

scientific article published on February 2010

Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?

scientific article

Pretargeting with the affinity enhancement system for radioimmunotherapy.

scientific article

Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy

scientific article

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

scientific article published on 29 April 2010

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

scientific article

Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence

scientific article published on 24 May 2007

Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study.

scientific article published on 14 May 2014

Radioimmunoconjugates for the treatment of cancer

scientific article

Radioimmunoconjugates for treating cancer: recent advances and current opportunities

scientific article

Radioimmunotherapy for Treatment of Acute Leukemia

scientific article published on March 2016

Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?

scientific article published on 29 October 2015

Radiolabeled Antibodies for Cancer Imaging and Therapy ⬇️

scientific article published on January 1, 2012

Radiolabeled antibodies for cancer treatment

scientific article published in December 2009

Report of the 6th International Workshop on PET in lymphoma

scientific article published on 7 March 2017

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials

scientific article

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

scientific article

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

article

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

scientific article published on September 2011

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

scientific article

Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma

scientific article published in December 2007

Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.

scientific article published in February 2010

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma

scientific article

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time

scientific article published on 07 May 2012

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

scientific article published in October 2000

Tumor immunotargeting using innovative radionuclides

scientific article

What can be expected from nuclear medicine tomorrow?

scientific article

¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

scientific article published on 8 May 2014

List of works by Françoise Kraeber-Bodéré

18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease

18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study.

99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography

A pretargeting system for tumor PET imaging and radioimmunotherapy

A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.

Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer

Assessment of a fully 3D Monte Carlo reconstruction method for preclinical PET with iodine-124

Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT.

BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principle

Challenges in nuclear medicine: innovative theranostic tools for personalized medicine

Clinical NECR in 18F-FDG PET scans: optimization of injected activity and variable acquisition time. Relationship with SNR.

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up

Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma

Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence

Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft

Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.

Consolidation par 90Y-epratuzumab en fractionné dans le lymphome B diffus à grandes cellules : résultats préliminaires d’une étude de phase II

Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

Current status and perspectives in peptide receptor radiation therapy

Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Does18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?

Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients

Détection laparoscopique des ganglions sentinelles dans le cancer localisé de la prostate : résultats obtenus chez 70 premiers patients

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

FDG-PET in Follicular Lymphoma Management ⬇️

Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.

First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumors.

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer

High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma

Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".

Immuno-PET for Clinical Theranostic Approaches ⬇️

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients

Improvement of radioimmunotherapy using pretargeting

Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma

Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients

Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma

Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data

Le point sur les avancées récentes de la radio-immunothérapie alpha

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients

Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors.

Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

Phéochromocytomes bilatéraux. Génétique et traitement

Preoperative localization of parathyroid lesions

Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer

Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?

Pretargeting with the affinity enhancement system for radioimmunotherapy.

Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence

Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study.

Radioimmunoconjugates for the treatment of cancer

Radioimmunoconjugates for treating cancer: recent advances and current opportunities

Radioimmunotherapy for Treatment of Acute Leukemia

Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?

Radiolabeled Antibodies for Cancer Imaging and Therapy ⬇️

Radiolabeled antibodies for cancer treatment

Report of the 6th International Workshop on PET in lymphoma

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma

Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

Tumor immunotargeting using innovative radionuclides